Full Year and Q4 2024 results - AstraZeneca
- Full Year and Q4 2024 results AstraZeneca
- AstraZeneca reports 38% jump in pre-tax profits to $8.7bn The Guardian
- AstraZeneca sales jump despite troubles in China Financial Times
- AstraZeneca Sales and Profit Outshine Estimates on Cancer Drugs Bloomberg
- AstraZeneca and GSK put spotlight on pharma as results loom Proactive Investors UK